Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-24 @ 10:50 PM
NCT ID:
NCT01076569
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of acute myeloid leukemia
* High-risk disease
* Treated on COG-AAML03P1 or COG-AAML0531
* Meets the following criteria:
* Initial remission with no known adverse risk factors
* High quantity and quality of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) available
* Highly enriched specimens with \>= 50% blast available
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT01076569
Study Brief:
Protocol Section:
NCT01076569